Annovis Bio ANVS
NYSE ANVS
$1.01 +0.03 (+2.95%)
As of: Oct 21, 2026 · 11:40 AM EDT

Annovis Bio (ANVS) Non-Current Assets (2019)

Updated

Annovis Bio's Non-Current Assets was $369,595 in Q4 2019.

Analysis

Annovis Bio (ANVS) Non-Current Assets (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 141.29 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 101.45 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 87.87 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 35.42 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 159.77 Bn
10 Annovis Bio 37.52 Mn -30.26 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 369,595.00
API Access

Annovis Bio Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=ANVS&period=max&api_key=YOUR_API_KEY